Moderate walking speed and survival association across 23-years follow-up in female patients with cardiovascular disease.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 Jan 2023
Historique:
received: 08 04 2022
revised: 16 08 2022
accepted: 06 09 2022
pubmed: 12 9 2022
medline: 15 12 2022
entrez: 11 9 2022
Statut: ppublish

Résumé

To estimate the association between average walking speed (WS), determined using a moderate 1-km treadmill-walking test (1 k-TWT), and all-cause mortality in female patients with stable cardiovascular disease (CVD). A sample of 431 patients (age 67 [34-88] years), performed a 1 k-TWT and were followed for all-cause mortality for up to 23 years. Variables significantly associated with mortality were determined by Cox proportional hazard models. Based on average WS during the 1k_TWT the sample was subdivided into tertiles, and mortality risk was calculated. Receiver-operating-characteristic curves were constructed to assess the discriminatory accuracy of WS for estimating survival. During a median follow-up of 10.4 years, a total of 135 deaths from any cause occurred, with an average mortality rate of 4.2%. The strongest predictor of mortality was WS (c-statistic for all-cause mortality 0.801, 95% confidence intervals: 0.51-1.11, p < 0.0001). Survival rate decreased from the fastest to the lowest tertile. Compared to the group with the lowest WS, the hazard ratios (95% confidence intervals) for the second and third tertiles were 0.73 (0.48-1.12) and 0.47 (0.25-0.91), respectively (p for trend <0.0001). Average WS maintained during a moderate treadmill-walk is inversely related to survival in female patients with CVD. The 1 k-TWT is a simple and useful tool for assessing progress and stratifying risk in women undergoing secondary prevention programs.

Identifiants

pubmed: 36089160
pii: S0167-5273(22)01324-9
doi: 10.1016/j.ijcard.2022.09.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

371-376

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None declared.

Auteurs

Andrea Raisi (A)

Center for Exercise Science and Sport, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy.

Valentina Zerbini (V)

Center for Exercise Science and Sport, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy. Electronic address: valentina.zerbini@unife.it.

Jonathan Myers (J)

Division of Cardiology, VA, Palo Alto, CA, USA; Stanford University School of Medicine, Stanford, CA, USA; Healthy Living for Pandemic Event Protection (HL-PIVOT) Network, Chicago, IL, USA.

Sabrina Masotti (S)

Center for Exercise Science and Sport, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy.

Tommaso Piva (T)

Center for Exercise Science and Sport, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy.

Rosario Lordi (R)

Center for Exercise Science and Sport, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy; Public Health Department, AUSL Ferrara, Italy.

Giorgio Chiaranda (G)

Public Health Department, AUSL Piacenza, Italy; General Directorship for Public Health and Integration Policy, Emilia-Romagna Region, Bologna, Italy.

Giovanni Grazzi (G)

Center for Exercise Science and Sport, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy; Healthy Living for Pandemic Event Protection (HL-PIVOT) Network, Chicago, IL, USA; Public Health Department, AUSL Ferrara, Italy.

Gianni Mazzoni (G)

Center for Exercise Science and Sport, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy; Public Health Department, AUSL Ferrara, Italy.

Simona Mandini (S)

Center for Exercise Science and Sport, Department of Neuroscience and Rehabilitation, University of Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH